Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers
- Status
- TERMINATED
- Phase
- PHASE1
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Evaluating TG4050 in Ovarian Carcinoma.
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
- Status
- TERMINATED
- Phase
- PHASE2
European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)
- Status
- COMPLETED
- Phase
- PHASE3
Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)
- Status
- COMPLETED
- Phase
- PHASE2
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3